Effectiveness of favipiravir in COVID-19 patients with risk factors for mortality: A real world experience from India.
S. Panchal (Mumbai, India), K. Venugopal (Chennai, India), A. Vora (Mumbai, India), A. Daxini (Mumbai, India), P. Dadhich (Ajmer, India), S. Bhagat (Mumbai, India), S. Patil (Mumbai, India), H. Barkate (Mumbai, India), S. Patil (Mumbai, India)
Source: Virtual Congress 2021 – COVID - 19 treatments
Session: COVID - 19 treatments
Session type: E-poster
Number: 3684
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Panchal (Mumbai, India), K. Venugopal (Chennai, India), A. Vora (Mumbai, India), A. Daxini (Mumbai, India), P. Dadhich (Ajmer, India), S. Bhagat (Mumbai, India), S. Patil (Mumbai, India), H. Barkate (Mumbai, India), S. Patil (Mumbai, India). Effectiveness of favipiravir in COVID-19 patients with risk factors for mortality: A real world experience from India.. 3684
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018
Evaluation of risk factors for mortality among ARDS patients in Hyderabad, south India Source: Eur Respir J 2007; 30: Suppl. 51, 581s Year: 2007
Real world evaluation of asthma control risk factors and management: findings from China national asthma control surveys Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania Source: Eur Respir J, 51 (2) 1700182; 10.1183/13993003.00182-2017 Year: 2018
Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019
Late Breaking Abstract - Identifying preventable early risk factors for asthma in Indigenous children: a population cohort study in Western Australia. Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020
Prevalence rate and risk factors for hospital readmissions for asthma in children and adolescents in a tropical setting Source: Eur Respir J 2002; 20: Suppl. 38, 535s Year: 2002
Epidemiology of COVID-19: global spread, risk factors for disease incidence, severity and mortality Source: Eur Respir Monogr 2021; 94: 14-27 Year: 2021
PARFAIT (Prevalence and risk factors of allergies in Turkey) study: results of adults Source: Eur Respir J 2006; 28: Suppl. 50, 241s Year: 2006
The results of the TB control during of it epidemic in Ukraine on the base of the TB incidence in risk groups studying Source: Eur Respir J 2003; 22: Suppl. 45, 518s Year: 2003
Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
The clinical features and the risk factors of teenagers cases with MDR-TB in Romania Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma? Source: Eur Respir J, 50 (3) 1700644; 10.1183/13993003.00644-2017 Year: 2017
Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP? Source: Eur Respir J 2004; 23: 103-105 Year: 2004
Interventions and service models for the people most at risk of tuberculosis, including refugees Source: International Congress 2016 – Respiratory infectious disease control in Europe Year: 2016
Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Qualitative phenomenological study informs the development of educational intervention for behaviour change to reduce morbidity and mortality in adults with chronic lung disease in rural India Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021
Smoking is a risk factor for TB infection, but is it an additional mortality risk? Source: Annual Congress 2011 - Management of tuberculosis Year: 2011